Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study "LIMITS"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 December 2012.

1 Jun 2005 20 Dec 2007 1 Apr 2012 1 Aug 2013 1 Dec 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts